
Jon E. Angell
Examiner (ID: 3741, Phone: (571)272-0756 , Office: P/1674 )
| Most Active Art Unit | 1635 |
| Art Unit(s) | 1635, 1637, 1674 |
| Total Applications | 1431 |
| Issued Applications | 721 |
| Pending Applications | 199 |
| Abandoned Applications | 530 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8176291
[patent_doc_number] => 08178128
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-05-15
[patent_title] => 'Nanoparticles containing polymeric nucleic acid homologs'
[patent_app_type] => utility
[patent_app_number] => 10/497783
[patent_app_country] => US
[patent_app_date] => 2002-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 45
[patent_no_of_words] => 22087
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/178/08178128.pdf
[firstpage_image] =>[orig_patent_app_number] => 10497783
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/497783 | Nanoparticles containing polymeric nucleic acid homologs | Dec 4, 2002 | Issued |
Array
(
[id] => 8829186
[patent_doc_number] => 20130130231
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-23
[patent_title] => 'Bioinformatically detectable group of novel viral regulatory genes and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/303778
[patent_app_country] => US
[patent_app_date] => 2002-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 54
[patent_figures_cnt] => 54
[patent_no_of_words] => 123220
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10303778
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/303778 | Bioinformatically detectable group of novel viral regulatory genes and uses thereof | Nov 25, 2002 | Abandoned |
Array
(
[id] => 7679162
[patent_doc_number] => 20030167490
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-04
[patent_title] => 'Gene silencing by systemic RNA interference'
[patent_app_type] => new
[patent_app_number] => 10/304930
[patent_app_country] => US
[patent_app_date] => 2002-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 13046
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 22
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0167/20030167490.pdf
[firstpage_image] =>[orig_patent_app_number] => 10304930
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/304930 | Gene silencing by systemic RNA interference | Nov 25, 2002 | Abandoned |
Array
(
[id] => 6668321
[patent_doc_number] => 20030113304
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-19
[patent_title] => 'Selective tissue site revascularization by combined focal injury and hematopoietic stem cell introduction'
[patent_app_type] => new
[patent_app_number] => 10/299079
[patent_app_country] => US
[patent_app_date] => 2002-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1776
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20030113304.pdf
[firstpage_image] =>[orig_patent_app_number] => 10299079
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/299079 | Selective tissue site revascularization by combined focal injury and hematopoietic stem cell introduction | Nov 18, 2002 | Abandoned |
Array
(
[id] => 6706349
[patent_doc_number] => 20030153083
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-14
[patent_title] => 'Selective killing of cells by activation of double-stranded rna dependent protein kniase-pkr'
[patent_app_type] => new
[patent_app_number] => 10/182269
[patent_app_country] => US
[patent_app_date] => 2002-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 10293
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 35
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0153/20030153083.pdf
[firstpage_image] =>[orig_patent_app_number] => 10182269
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/182269 | Selective killing of cells by activation of double-stranded rna dependent protein kniase-pkr | Nov 14, 2002 | Abandoned |
Array
(
[id] => 4455174
[patent_doc_number] => 07892484
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-02-22
[patent_title] => 'Methods and compositions for neutralizing anthrax and other bioagents'
[patent_app_type] => utility
[patent_app_number] => 10/291336
[patent_app_country] => US
[patent_app_date] => 2002-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7778
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/892/07892484.pdf
[firstpage_image] =>[orig_patent_app_number] => 10291336
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/291336 | Methods and compositions for neutralizing anthrax and other bioagents | Nov 7, 2002 | Issued |
Array
(
[id] => 6683912
[patent_doc_number] => 20030119776
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-26
[patent_title] => 'Modulation of Fas and FasL expression'
[patent_app_type] => new
[patent_app_number] => 10/280274
[patent_app_country] => US
[patent_app_date] => 2002-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7755
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0119/20030119776.pdf
[firstpage_image] =>[orig_patent_app_number] => 10280274
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/280274 | Modulation of Fas and FasL expression | Oct 24, 2002 | Issued |
Array
(
[id] => 6821215
[patent_doc_number] => 20030219376
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-27
[patent_title] => 'Progression elevated Gene-3 and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/277603
[patent_app_country] => US
[patent_app_date] => 2002-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 39
[patent_no_of_words] => 54865
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0219/20030219376.pdf
[firstpage_image] =>[orig_patent_app_number] => 10277603
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/277603 | Progression elevated Gene-3 and uses thereof | Oct 21, 2002 | Abandoned |
Array
(
[id] => 6792526
[patent_doc_number] => 20030087870
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-08
[patent_title] => ' Method of treating fibrosis'
[patent_app_type] => new
[patent_app_number] => 10/264361
[patent_app_country] => US
[patent_app_date] => 2002-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 17908
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0087/20030087870.pdf
[firstpage_image] =>[orig_patent_app_number] => 10264361
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/264361 | Methods for reducing TGF-β production and for promoting repair of liver damage | Oct 2, 2002 | Issued |
Array
(
[id] => 7357992
[patent_doc_number] => 20040014057
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-22
[patent_title] => 'Targeted chromosomal genomic alterations with modified single stranded oligonucleotides'
[patent_app_type] => new
[patent_app_number] => 10/261185
[patent_app_country] => US
[patent_app_date] => 2002-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 47378
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20040014057.pdf
[firstpage_image] =>[orig_patent_app_number] => 10261185
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/261185 | Targeted chromosomal genomic alterations with modified single stranded oligonucleotides | Sep 26, 2002 | Issued |
Array
(
[id] => 6788124
[patent_doc_number] => 20030139363
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-24
[patent_title] => 'Methods and compositions for RNAi mediated inhibition of viral gene expression in mammals'
[patent_app_type] => new
[patent_app_number] => 10/259226
[patent_app_country] => US
[patent_app_date] => 2002-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 18411
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0139/20030139363.pdf
[firstpage_image] =>[orig_patent_app_number] => 10259226
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/259226 | Methods and compositions for RNAi mediated inhibition of gene expression in mammals | Sep 26, 2002 | Issued |
Array
(
[id] => 6792064
[patent_doc_number] => 20030087408
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-08
[patent_title] => 'Tumor-specific P450 protein'
[patent_app_type] => new
[patent_app_number] => 10/252850
[patent_app_country] => US
[patent_app_date] => 2002-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6560
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0087/20030087408.pdf
[firstpage_image] =>[orig_patent_app_number] => 10252850
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/252850 | Tumor-specific P450 protein | Sep 22, 2002 | Abandoned |
Array
(
[id] => 6668870
[patent_doc_number] => 20030113854
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-19
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/245127
[patent_app_country] => US
[patent_app_date] => 2002-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 116
[patent_figures_cnt] => 116
[patent_no_of_words] => 44998
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20030113854.pdf
[firstpage_image] =>[orig_patent_app_number] => 10245127
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/245127 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Sep 16, 2002 | Abandoned |
Array
(
[id] => 6683273
[patent_doc_number] => 20030119137
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-26
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/245911
[patent_app_country] => US
[patent_app_date] => 2002-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 116
[patent_figures_cnt] => 116
[patent_no_of_words] => 44996
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0119/20030119137.pdf
[firstpage_image] =>[orig_patent_app_number] => 10245911
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/245911 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Sep 16, 2002 | Abandoned |
Array
(
[id] => 6683265
[patent_doc_number] => 20030119129
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-26
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/245479
[patent_app_country] => US
[patent_app_date] => 2002-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 116
[patent_figures_cnt] => 116
[patent_no_of_words] => 44980
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0119/20030119129.pdf
[firstpage_image] =>[orig_patent_app_number] => 10245479
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/245479 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Sep 16, 2002 | Abandoned |
Array
(
[id] => 6683267
[patent_doc_number] => 20030119131
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-26
[patent_title] => ' Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/245772
[patent_app_country] => US
[patent_app_date] => 2002-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 116
[patent_figures_cnt] => 116
[patent_no_of_words] => 44992
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0119/20030119131.pdf
[firstpage_image] =>[orig_patent_app_number] => 10245772
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/245772 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Sep 16, 2002 | Abandoned |
Array
(
[id] => 6668876
[patent_doc_number] => 20030113860
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-19
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/245878
[patent_app_country] => US
[patent_app_date] => 2002-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 116
[patent_figures_cnt] => 116
[patent_no_of_words] => 45008
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20030113860.pdf
[firstpage_image] =>[orig_patent_app_number] => 10245878
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/245878 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Sep 15, 2002 | Abandoned |
Array
(
[id] => 6761303
[patent_doc_number] => 20030124665
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-03
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/245810
[patent_app_country] => US
[patent_app_date] => 2002-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 116
[patent_figures_cnt] => 116
[patent_no_of_words] => 45008
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0124/20030124665.pdf
[firstpage_image] =>[orig_patent_app_number] => 10245810
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/245810 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Sep 15, 2002 | Abandoned |
Array
(
[id] => 6683266
[patent_doc_number] => 20030119130
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-26
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/245499
[patent_app_country] => US
[patent_app_date] => 2002-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 116
[patent_figures_cnt] => 116
[patent_no_of_words] => 45034
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0119/20030119130.pdf
[firstpage_image] =>[orig_patent_app_number] => 10245499
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/245499 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Sep 15, 2002 | Abandoned |
Array
(
[id] => 6813642
[patent_doc_number] => 20030073192
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-17
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/245055
[patent_app_country] => US
[patent_app_date] => 2002-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 116
[patent_figures_cnt] => 116
[patent_no_of_words] => 41236
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0073/20030073192.pdf
[firstpage_image] =>[orig_patent_app_number] => 10245055
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/245055 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Sep 15, 2002 | Abandoned |